Legal Representation
Attorney
Jodi A. DeSchane
USPTO Deadlines
Next Deadline
1675 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240730)
Due Date
July 30, 2030
Grace Period Ends
January 30, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 30, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 30, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 25, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jun 25, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| May 15, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Apr 17, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| May 7, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 18, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 17, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Apr 17, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 17, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 17, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 17, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 22, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 22, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 2, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 14, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 3, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 26, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 24, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Hyaluronic acid and the sodium salt therefrom, namely, sodium hyaluronate, sold as a raw chemical for use in manufacturing processes, namely, for use in compounding pharmaceuticals or cosmetics
First Use Anywhere:
20170000
First Use in Commerce:
20170000
Class 005
Pharmaceutical preparations containing hyaluronic acid, sodium hyaluronate, or a derivative of hyaluronic acid for use in eye surgery, repair of flexible tissue, and injectable drug delivery compounds used as a facilitating agent for other pharmaceuticals
First Use Anywhere:
20170000
First Use in Commerce:
20170000
Class 035
Regulatory submission management, namely, assisting others in preparing documents and information for their filing of applications for new drugs and medical devices with governmental regulatory bodies
First Use Anywhere:
20170000
First Use in Commerce:
20170000
Class 039
Packaging of custom designed and manufactured pharmaceuticals for others, namely, filling syringes, vials and bags, labeling, pouching, and traying
First Use Anywhere:
20170000
First Use in Commerce:
20170000
Class 040
Contract manufacturing in the field of fermentation services for microbial and yeast fermentation; custom formulation of pharmaceuticals
First Use Anywhere:
20170000
First Use in Commerce:
20170000
Class 042
Designing and developing pharmaceuticals; inspection of custom designed and manufactured pharmaceuticals
First Use Anywhere:
20170000
First Use in Commerce:
20170000
Class 045
Regulatory compliance consulting in the field of pharmaceuticals and medical devices
First Use Anywhere:
20170000
First Use in Commerce:
20170000
Classification
International Classes
001
005
035
039
040
042
045